Scholarly Index
Renzo Alfini
GlaxoSmithKline (France); 1,095 total citations; 54 total publications; best world rank #240
GlaxoSmithKline (France)
1,095Total citations
54Total publications
18H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Bacterial Infections and Vaccines | 2021-2025 | 325 | FR 21 | 85.17 |
| Escherichia coli research studies | 2021-2025 | 240 | FR 16 | 84.02 |